3,881
edits
Changes
HAEM5:Volunteer Assignments and Opportunities (view source)
Revision as of 18:11, 23 December 2023
, 18:11, 23 December 2023no edit summary
|-
|-
|Indolent T-cell lymphoma of the gastrointestinal tract||Disease|| || || || || ||SK|| ||
|Indolent T-cell lymphoma of the gastrointestinal tract||Disease|| || || || || ||SK|| ||
|
|Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract
|Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
|Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
|
|Pending
|
|
|
|
|-
|-
|Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract||Disease|| || || || || ||SK|| ||
|Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract||Disease|| || || || || ||SK|| ||
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|Enteropathy-associated T-cell lymphoma||Disease|| || || || || ||SK|| ||
|Enteropathy-associated T-cell lymphoma||Disease|| || || || || ||SK|| ||
|
|Enteropathy-Associated T-cell Lymphoma
|*Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD
|*Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD
|
|Complete
|
|1/21/2021
|
|
|-
|-
|Monomorphic epitheliotropic intestinal T-cell lymphoma||Disease|| || || || || ||SK|| ||
|Monomorphic epitheliotropic intestinal T-cell lymphoma||Disease|| || || || || ||SK|| ||
|
|Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
|Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
|Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
|
|Pending
|
|
|
|
|-
|-
|Intestinal T-cell lymphoma, NOS||Disease|| || || || || ||SK|| ||
|Intestinal T-cell lymphoma, NOS||Disease|| || || || || ||SK|| ||
|
|Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)
|Derick Okwan MD, PhD (Stanford Medicine, CA) Sumire Kitahara MD (Cedars-Sinai, CA)
|Derick Okwan MD, PhD (Stanford Medicine, CA) Sumire Kitahara MD (Cedars-Sinai, CA)
|
|Complete
|
|9/26/2022
|
|
|-
|-
|Hepatosplenic T-cell lymphoma||Disease|| || || || || ||SK|| ||
|Hepatosplenic T-cell lymphoma||Disease|| || || || || ||SK|| ||
|
|Hepatosplenic T-cell Lymphoma
|*Michelle Don, MD, MS
|Michelle Don, MD, MS
|
|Complete
|
|1/21/2021
|
|
|-
|-